May 6 |
FibroGen GAAP EPS of -$0.33 beats by $0.20, revenue of $55.9M beats by $19.45M
|
May 6 |
FibroGen Reports First Quarter 2024 Financial Results
|
May 3 |
FibroGen Q1 2024 Earnings Preview
|
Apr 29 |
FibroGen to Report First Quarter 2024 Financial Results
|
Apr 24 |
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Presented at the 2024 American Society of Clinical Oncolo...
|
Apr 23 |
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
|
Apr 16 |
Ultragenyx (RARE) Meets Efficacy Goal in Neuro Disease Study
|
Apr 16 |
Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
|
Apr 12 |
RallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up
|
Apr 12 |
Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year?
|